Imuran Alternatives Compared
| Imuran | Vedolizumab | Azulfidine EN-tabs |
|
|---|
| Imuran (azathioprine) | Vedolizumab | Azulfidine EN-tabs (sulfasalazine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Autoimmune Hepatitis, Atopic Dermatitis, Chronic Active Hepatitis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease... View more |
Prescription only
Prescribed for Ulcerative Colitis, Crohn's Disease - Maintenance, Crohn's Disease. vedolizumab may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Inflammatory Bowel Disease, Juvenile Rheumatoid Arthritis, Lymphocytic Colitis, Rheumatoid Arthritis, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance... View more |
Related suggestions Ulcerative Colitis
Popular comparisons
|
|||||||||||||||
| More about Imuran (azathioprine) | More about Vedolizumab | More about Azulfidine EN-tabs (sulfasalazine) | ||||||||||||||||
| Generic Status | ||||||||||||||||||
|
No lower-cost generic available |
||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Imuran has an average rating of 5.9 out of 10 from a total of 64 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 34% reported a negative effect. |
Vedolizumab has an average rating of 5.7 out of 10 from a total of 136 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 33% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
Common side effects include:
See also: Imuran side effects in more detail. |
Commonly reported side effects include:
See also: vedolizumab side effects in more detail. |
Common side effects include:
See also: Azulfidine EN-tabs side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Imuran prices and generic prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Azulfidine EN-tabs prices and generic prices |
||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other azathioprine brands include: Azasan | Entyvio | Other sulfasalazine brands include: Azulfidine | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
2 hours |
600 hours |
10 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 373 drugs are known to interact with Imuran:
|
A total of 131 drugs are known to interact with vedolizumab:
|
A total of 233 drugs are known to interact with Azulfidine EN-tabs:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
March 20, 1968 |
N/A |
June 20, 1950 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
|
||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.